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Abstract. 
 
The highly organized pattern of acetylcho-
linesterase (AChE) molecules attached to the basal 
lamina of the neuromuscular junction (NMJ) suggests 
the existence of specific binding sites for their precise 
localization. To test this hypothesis we immunoaffinity 
purified quail globular and collagen-tailed AChE forms 
and determined their ability to attach to frog NMJs 
which had been pretreated with high-salt detergent 
buffers. The NMJs were visualized by labeling acetyl-
choline receptors (AChRs) with TRITC-
 
a
 
-bungaro-
toxin and AChE by indirect immunofluorescence; there 
was excellent correspondence (
 
.
 
97%) between the dis-
tribution of frog AChRs and AChE. Binding of the 
exogenous quail AChE was determined using a species-
specific monoclonal antibody. When frog neuromuscu-
lar junctions were incubated with the globular G
 
4
 
/G
 
2
 
 
quail AChE forms, there was no detectable binding 
above background levels, whereas when similar prepa-
rations were incubated with the collagen-tailed A
 
12
 
 
AChE form 
 
.
 
80% of the frog synaptic sites were also 
immunolabeled for quail AChE attached. Binding of 
the A
 
12
 
 quail AChE was blocked by heparin, yet could 
not be removed with high salt buffer containing deter-
gent once attached. Similar results were obtained using 
empty myofiber basal lamina sheaths produced by me-
chanical or freeze-thaw damage. These experiments 
show that specific binding sites exist for collagen-tailed 
AChE molecules on the synaptic basal lamina of the 
vertebrate NMJ and suggest that these binding sites 
comprise a “molecular parking lot” in which the AChE 
molecules can be released, retained, and turned over.
 
A
 
cetylcholinesterase
 
 (AChE),
 
1
 
 the enzyme re-
sponsible for hydrolyzing acetylcholine released
at the neuromuscular junction, is localized in the
synaptic cleft interposed between the nerve terminals and
the postsynaptic membrane, where a substantial fraction
of the enzyme is attached to the synaptic basal lamina
(McMahan et al., 1978; for review see Massoulié et al.,
1993). The distribution of AChE molecules on the synap-
tic basal lamina closely matches the distribution of nico-
tinic acetylcholine receptors (AChRs), as well as other
molecules on the pre- and postsynaptic membranes, indi-
cating a high degree of organization of the molecular com-
ponents at the neuromuscular junction (reviewed in Hall
and Sanes, 1993). Although most of the AChE expressed
in muscle can be solubilized, the AChE molecules at-
tached to the synaptic basal lamina in birds and mammals
are not removed by high ionic strength buffers, detergents,
or chaotropic agents (Rossi and Rotundo, 1993). On the
other hand, the basal lamina–associated AChE can be de-
tached using mixtures of collagenase and other proteases
(Hall and Kelly, 1971; Betz and Sakmann, 1973) or highly
purified collagenase (Rossi and Rotundo, 1993).
The junctional AChE molecules can be contributed ei-
ther by the muscle fibers (Anglister and McMahan, 1985;
De La Porte et al., 1986) or by the motoneurons (Anglis-
ter, 1991), with the former most likely contributing most of
the basal lamina–associated enzyme. After denervation,
there is a large decrease in the density of AChE molecules
at the neuromuscular synapse which can be restored by
electrical stimulation of the denervated muscles or by their
reinnervation either at the original (Lømo and Slater, 1980)
or at ectopic sites (Weinberg and Hall, 1979). Further-
more, regenerating myofibers re-accumulate basal lamina
AChE at original synaptic sites in the absence of innerva-
tion (Anglister and McMahan, 1985). Altogether, these
studies show that muscle fibers can produce synaptic
AChE and, moreover, indicate that the information neces-
sary for organizing AChE molecules on the synaptic basal
lamina is associated either with the muscle or contained
within the synaptic matrix itself.
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a
 
-bungarotoxin; HSB, high salt buffer; LSB,
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In birds and mammals the predominant, if not exclusive,
form of AChE attached to the synaptic basal lamina is the
asymmetric A
 
12
 
 form of the enzyme consisting of three tet-
ramers covalently linked to a three-stranded collagen-like
tail (reviewed in Massoulié et al., 1993). The collagen-like
tail is generally thought to be required for attachment of
AChE to the extracellular matrix. The observation that
only proteolysis using collagenase can remove the junc-
tional AChE is consistent with this view and suggests that
the AChE molecules become covalently attached to com-
ponents of the specialized extracellular matrix at the neu-
romuscular synapse.
Tissue-cultured muscle cells express the same oligo-
meric forms of AChE as adult muscle including the globu-
lar monomeric (G), dimeric (G
 
2
 
), and tetrameric (G
 
4
 
) forms
and the asymmetric collagen-tailed form (A
 
12
 
). When the
myotubes differentiate into actively contracting myofibers
they assemble the A
 
12
 
 collagen-tailed form which in turn
becomes organized into clusters on the extracellular ma-
trix overlying individual myonuclei (Rossi and Rotundo,
1992). These clustered AChE molecules behave very much
like the AChE attached to the synaptic basal lamina in
that they cannot be removed using high ionic strength
buffers or detergents, yet can be detached using purified
collagenase. When these forms are externalized at the sur-
face plasma membrane they appear to transiently interact
with heparan sulfate-like proteoglycans before attaching
more permanently to the extracellular matrix (Rossi and
Rotundo, 1996). Although these studies show that the A
 
12
 
AChE form is selectively retained on the extracellular ma-
trix in the vicinity of the myonuclei, they do not distinguish
between several possible mechanisms of targeting includ-
ing association with the extracellular matrix at the sites of
externalization, or, more interestingly, preferential attach-
ment to specific sites organized on the basal lamina.
In the present study we sought to determine whether
specific attachment sites for the collagen-tailed AChE
form were situated on the synaptic basal lamina of adult
muscle. Using purified quail globular and collagen-tailed
AChE forms, we demonstrate that only the collagen-tailed
form of the enzyme can bind to the frog neuromuscular
junction where it attaches to the extracellular matrix.
These experiments show that specific sites exist for localiz-
ing AChE at the neuromuscular synapse and that the
properties of these sites are shared across species as diver-
gent as amphibians and birds. Furthermore, since AChE
molecules can be turned over at the neuromuscular junc-
tion while maintaining their appropriate distributions (Kas-
przak and Salpeter, 1985), our observations suggest that a
“molecular parking lot” exists for the insertion and re-
moval of this enzyme on the synaptic basal lamina.
 
Materials and Methods
 
Preparation of Tissues and Empty Basal
Lamina Sheaths
 
Frogs (
 
Rana pipiens
 
) obtained from Hazen Co. (Alburg, VT) were housed
at 20–22
 
8
 
C in the animal care facility at the Hebrew University Hadassah
Medical School under veterinary supervision and fed twice weekly. Fro-
zen sections of frog muscle, 30 
 
m
 
m thick, were cut from the anterior tibia-
lis muscle, mounted on gelatin-coated slides, and stored frozen until used.
Before extraction the slides were warmed to room temperature, and a
0.5-cm high by 1.2-cm diam plastic ring was placed around the sections
and held in place with rubber cement. The plastic rings formed the wells in
which the various extractions, incubations, and immunohistochemical pro-
cedures were performed.
Empty basal lamina sheaths of cutaneous pectoris muscles were pre-
pared as described in detail elsewhere (Anglister et al., 1994
 
a
 
). Muscles
were damaged by freezing or crushing and were denervated by excision
and removal of a 1–2-cm segment of the second spinal nerve near the ver-
tebral column. The frogs were X-irradiated once on each of the first three
days following surgery to prevent regeneration of the muscle fibers from
the remaining satellite cells. After allowing 5–6 wk for degeneration of the
muscle fibers, the sheaths of the cutaneous pectoris muscles were dis-
sected, pinned in small chambers, and extracted with several changes of
borate extraction buffer (see below). All extractions and incubations were
carried out in the 150-
 
m
 
l chamber volume. When necessary, the chambers
were sealed by pressing a 2.5-cm diam glass coverslip onto the surface to
prevent evaporation.
 
Isolation and Purification of Avian AChE Forms
 
The globular and collagen-tailed AChE forms were isolated from tissue-
cultured quail myotubes by preparative sucrose gradient sedimentation as
previously described (Rotundo, 1984
 
a
 
). The pooled fractions containing
the G
 
4
 
 tetramers and the G
 
2
 
 dimers (globular forms) or A
 
12
 
 collagen-
tailed AChE forms were diluted with borate buffer (see below) and
passed through a 1-ml immunoaffinity column made by coupling the mono-
clonal anti-avian AChE antibody 1A2 (Rotundo, 1984
 
b
 
) to CNBr acti-
vated Sepharose 2B (Pharmacia LKB Biotechnology, Piscataway, NJ) at a
concentration of 1 mg IgG/ml swelled gel. After washing the column with
additional buffer the enzyme was eluted with 2 mM triethanolamine, pH
11, with 1 M NaCl and 100-
 
m
 
l fractions collected in microfuge tubes con-
taining 50 
 
m
 
l 0.5 M Tris, pH 7. The fractions containing the catalytically
active AChE forms were pooled, concentrated, and stored frozen until
used. The concentration of AChE protein was estimated by enzymatic as-
say using the turnover number for chicken AChE, 1.45 mmol/min/mg pro-
tein, determined by Vigny et al. (1978). The stock solutions of the A
 
12
 
 and
G
 
4
 
/G
 
2
 
 were 97 ng/ml and 23 ng/ml, respectively.
 
Extraction of AChE from Tissue Sections and Transfer 
of Quail Enzyme
 
Tissue sections and empty basal lamina sheaths were pre-extracted with
detergent-containing buffer before all experiments to remove muscle
plasma membranes, soluble proteins, and/or cellular debris that could in-
terfere with access to the synaptic basal lamina. All extractions were car-
ried out in microwells using borate extraction buffer consisting of 20 mM
sodium borate, pH 9.0, 5 mM EDTA, 1 M NaCl, 0.5% Triton X-100, and
5 mg/ml bovine serum albumin high salt buffer (HSB), unless otherwise
indicated. In some experiments the salt concentration was reduced to
130 mM low salt buffer (LSB) and/or the Triton X-100 was eliminated.
Because of the small size of the tissue sections, protease inhibitors were
generally not included in the extraction buffers. However, the sections
were always washed with several changes to dilute and remove the ex-
tracted proteins.
After extraction, the tissue sections or empty basal lamina sheaths were
preincubated for 30 min in HSB containing 5 mg/ml each of bovine serum
albumin, chicken ovalbumin, and gelatin (all from Sigma Chem. Co., St.
Louis, MO) which have isoelectric points in the same range as avian
AChE. The addition of this protein mixture was essential in order to re-
duce nonspecific binding of AChE to the tissues. The stock AChE solu-
tions were diluted 1:50–1:20 in HSB containing the protein mix, to give
1–2 ng AChE/well final, and the NaCl concentration was adjusted to 0.5 M.
This solution was placed in the wells, 100 
 
m
 
l/well, and the ionic strength
lowered to 0.3 M stepwise over a period of 2 h to reduce the chances of the
collagen-tailed AChE form aggregating which can occur at salt concentra-
tions below 0.3 M. After adjustment to 0.3 M NaCl the sections were incu-
bated overnight at room temperature on a rotary platform. The next day
the NaCl concentration was lowered to 0.25–0.15 M NaCl to reduce de-
tachment of bound AChE, the sections rinsed with LSB, and the samples
prepared for immunofluorescence. This procedure was modified slightly
for use with the empty basal lamina sheaths. For these thicker samples the
amount of quail AChE was reduced by a half, the protein added directly
to HSB adjusted to 0.3 M NaCl, and the incubations were performed for
2 d in the microchambers sealed with a glass coverslip. 
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The fraction of the quail AChE that bound to the tissue sections was
determined biochemically by treating frozen sections of frog muscle
mounted on glass slides with diisopropylfluorophosphate, to irreversibly
inhibit AChE activity, followed by extensive washing to remove unre-
acted inhibitor. The sections were then incubated overnight with HSB
containing the protein mixture as described above, either with or without
A
 
12
 
 or G
 
4
 
/G
 
2
 
 AChE. The sections were rinsed to remove unbound en-
zyme, scraped into 100-
 
m
 
l HSB and sonicated to disperse the tissue. Ali-
quots of the tissue extract were assayed for AChE activity, together with
samples of the AChE solution before incubation with the tissue sections,
to determine the percent AChE bound. In both cases, only a very small
percentage of the total AChE added actually bound to the tissue sections,
1.0% and 1.5% for the A
 
12
 
 and G
 
4
 
/G
 
2
 
 AChE forms, respectively. Al-
though small amounts of both globular and collagen-tailed AChE binding
could be detected biochemically, on the order of about 10 pg each, most of
this probably reflects nonspecific binding since the available surface area
of the junctional regions on these frozen sections is 
 
,
 
0.1% of the total
cross-sectional area. Therefore, in practice, it is not possible to estimate
the extent of specific AChE binding in these experiments and for this rea-
son we used immunofluorescence localization of the quail AChE.
 
Immunofluorescence Localization of AChE and 
Labeling of AChR
 
After incubation with purified AChE forms, the tissue samples were
washed with several chamber volumes of 10 mM PBS, pH 7.4, containing
10% horse serum (PBS/HS), to remove unbound enzyme and saturate
nonspecific binding sites on the tissue sections. The sections were incu-
bated with PBS/HS containing 20 
 
m
 
g/ml 1A2 anti-avian AChE mono-
clonal antibody for 60 min followed by three washes of PBS/HS over a 30–
60-min period. The second antibody was fluorescein-conjugated rabbit
anti–mouse IgG (Cappel Laboratories, Malvern, PA) used at a concentra-
tion of 10 
 
m
 
g/ml in PBS/HS, for 60 min. After washing with additional
PBS/HS, samples were rinsed with PBS alone, fixed with 4% paraformal-
dehyde in PBS, and mounted in 90% glycerol/10% 100 mM bicarbonate
buffer, pH 9.5, containing 1 mg/ml phenylenediamine (Sigma) to reduce
photobleaching. In some experiments 1 
 
m
 
g/ml TRITC-conjugated 
 
a
 
-bun-
garotoxin (
 
a
 
Btx) (Molecular Probes, Inc., Eugene, OR) was included to-
gether with the first antibody to label the frog nicotinic acetylcholine re-
ceptors, and the frog AChE was localized using either a cross-reacting
polyclonal antibody generated against the enzyme isolated from the elec-
tric ray (antibody R80, a generous gift from Dr. P. Taylor, U.C. San Di-
ego, La Jolla, CA) or by immunocytochemistry following the procedure of
Karnovsky (1964).
 
Quantitation of AChR and AChE Colocalization
 
The frog neuromuscular junction consists of several nerve terminal branches
coursing in parallel to the long axis of the muscle fiber. On cross sections
of muscle fibers these synaptic gutters appear as a series of several periph-
erally localized clusters of AChR and AChE molecules (see Figs. 2 and 3).
To determine the extent of colocalization, all TRITC-
 
a
 
Btx labeled AChR
clusters were counted on three randomly chosen cross sections of frog
muscle per slide. The fraction of TRITC-
 
a
 
Btx labeled AChR clusters that
were also positive for fluorescein-labeled AChE was then determined and
expressed as percent of total. At least three slides per group were quanti-
tated and the results expressed as the mean percentage 
 
6
 
 SEM.
 
Results
 
Distribution of Nuclei at the Frog
Neuromuscular Junction
 
In both mammals and birds there is an accumulation of
nuclei in the innervated regions of the muscle fibers that
express higher levels of AChR (Merlie and Sanes, 1985;
Klarsfeld et al., 1991; Simon et al., 1992) and AChE (Jas-
min et al., 1993; Michel et al., 1995; Legay et al., 1995)
transcripts. To determine the numbers and distribution of
myonuclei at frog neuromuscular junctions, teased fibers
from the cutaneous pectoris muscles were stained his-
tochemically for AChE (Karnovsky, 1964) and the nuclei
labeled with HOECHST 33342 (Fig. 1). The average neu-
romuscular junction in the cutaneous pectoris muscle is lo-
cated along a 340 
 
6
 
 50 
 
m
 
m (mean 
 
6
 
 SEM, 
 
n
 
 
 
5
 
 24) long
central segment of the myofiber and has about 3–4 nuclei
distributed along its length. These myonuclei are typically
elongated, sausage-shaped, organelles that can be easily
distinguished from the rounded nuclei in the Schwann
cells, fibroblasts, and satellite cells. The nuclei within the
innervated region of the fibers were counted and com-
pared to the distribution of nuclei within the same length
of non-innervated regions in the same fibers. In these fi-
bers the ratio of junctional to extrajunctional nuclei was
1.09 
 
6
 
 0.04 (mean 
 
6
 
 SEM; 
 
n
 
 
 
5
 
 24). Thus, in contrast to
higher vertebrates where a dozen or more disc-shaped nu-
clei can be distributed immediately beneath the sites of
nerve-muscle contact, at the frog neuromuscular junction
there does not appear to be such an accumulation of myo-
nuclei. These observations indicate that, in frog, the AChE
molecules that are destined to become incorporated at the
neuromuscular junction must move long distances follow-
ing translation before their extracellular attachment at
precise and orderly locations on the synaptic basal lamina
of the elongated junction.
 
Attachment of Acetylcholinesterase to the Frog 
Neuromuscular Junction
 
This initial study was performed to determine the extract-
ability of frog AChE and the extent to which the AChR
and AChE remained colocalized following incubation
with extraction buffers. Frog muscles were pretreated so
that synaptic sites would retain the putative “association
sites” for AChE while releasing at least some of the frog
AChE from those sites. We have previously shown that
AChE is poorly extracted from quail and rat neuromuscu-
lar junctions even using high ionic strength buffers, with or
without detergents (Rossi and Rotundo, 1993). Similar ex-
Figure 1. Distribution of muscle nuclei at the frog neuromuscular
junction. Frog cutaneous pectoris muscles were pinned at resting
length in Silgard-coated dishes and the neuromuscular junctions
visualized by histochemically staining for AChE followed by 60
min incubation in frog Ringer’s containing 100 U/ml of collage-
nase (Sigma type IV) to facilitate teasing the fibers free of fibro-
blasts and Schwann cells. After fixation with 4% paraformalde-
hyde in PBS and staining of nuclei with HOECHST 33342, the
fibers were teased and mounted in glycerol/phenylenediamine.
The myonuclei in frog muscle have the typical elongated shape
characteristic of myonuclei in other species, and can be easily dis-
tinguished from the rounded nuclei in the Schwann cells and fi-
broblasts. In contrast to mammals and birds, there is no accumu-
lation of nuclei at the frog neuromuscular junction. Bar, 50 mm. 
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traction procedures were applied to frog muscles, and the
extent to which the AChR and AChE clusters remained
colocalized under the different conditions was examined
as follows. Frozen sections of anterior tibialis muscle were
incubated with frog Ringer’s solution, LSB, or HSB, with
or without detergent, for either 90 min or overnight. The
distribution of AChR and AChE were examined by incu-
bating the sections with TRITC-
 
a
 
Btx to label AChR and
by indirect immunofluorescence to label AChE (Fig. 2).
The different extractions had only a small effect on the in-
tensity of AChR and AChE staining, indicating that under
the conditions of this study most of these molecules re-
mained attached to the frog muscle frozen sections through-
out the incubation period. These results, presented in Ta-
ble I, indicate that the distribution of AChR clusters
accurately matches the distribution of AChE molecules
even after extensive extraction with high salt and deter-
gent containing buffers. Similar results were obtained us-
ing whole mounts of cutaneous pectoris muscle (data not
shown).
 
Binding of Quail Collagen-tailed AChE Molecules to 
the Frog Neuromuscular Junction
 
Newly synthesized A
 
12
 
 AChE molecules undergo transient
electrostatic interactions with components of the extracel-
lular matrix before becoming more permanently attached
(Rossi and Rotundo, 1996). The initial interactions are
blocked in the presence of heparin, whereas once the A
 
12
 
molecules are attached, heparin cannot remove them.
These observations suggest that specific attachment sites
for the A
 
12
 
 AChE form exist on the extracellular matrix
and that the availability of such sites at the neuromuscular
junctions could determine the distribution of AChE on the
synaptic basal lamina.
To determine whether exogenous quail AChE could at-
tach to specific sites on frog muscle, purified globular G
 
4
 
/G
 
2
 
or collagen-tailed A
 
12
 
 forms, prepared from tissue-cul-
tured quail myotubes as described in Materials and Meth-
ods, were incubated with high salt-detergent extracted sec-
tions of frog muscle under conditions where the ionic
strength of the medium could be gradually reduced. After
washing the chambers to remove unbound enzyme, the
sections were incubated with TRITC-
 
a
 
Btx to localize
AChRs and mAb 1A2 to localize quail AChE (Fig. 3). The
monoclonal anti-AChE antibody used in these experi-
ments is species-specific and does not recognize the frog
Figure 2. Localization of AChR and frog AChE at the frog neuromuscular junction; effects of extraction procedures. Frozen sections of
anterior tibialis muscle were extracted for 90 min at room temperature in either frog Ringer’s solution, LSB, or HSB before localizing
sites of AChR accumulation using TRITC-aBtx and frog AChE using the polyclonal antibody R80. Upper panels show the distribution
of AChR and the lower panels show the corresponding distribution of frog AChE in the same fields. (A–B) Muscle sections incubated in
frog Ringer’s solution; (C–D) sections extracted with LSB; and (E–F) sections extracted with HSB. In all cases there was a high degree
of correspondence between the sites of AChR and AChE localization, regardless of whether the sections were extracted with high ionic
strength buffers and/or detergents, indicating that the sites of AChE attachment are preserved during extraction and can still be identi-
fied using AChR as a marker.
 
Table I. Colocalization of AChR and AChE after Different 
Extraction Procedures
 
Extraction buffer
1st extraction
Overnight
extraction
Percent colocalization of
AChE and AChR clusters
 
Ringer’s
 
2
 
93.0 
 
6
 
 3.4
HSB 
 
1
 
 TX-100 Ringer’s 95.6 
 
6
 
 2.2
HSB 
 
1
 
 TX-100 HSB 
 
1
 
 TX-100 97.1 
 
6
 
 1.6
Minus Detergent Plus Detergent
Ringer’s
 
2
 
94.6 
 
6
 
 3.4 97.6 
 
6
 
 2.3
LSB
 
2
 
98.3 
 
6
 
 1.6 98.6 
 
6
 
 1.3
HSB
 
2
 
99.5 
 
6
 
 0.5 98.6 
 
6
 
 1.5
 
Frozen sections of frog anterior tibialis muscle were extracted with either frog
Ringer’s solution, HSB plus detergent, or LSB plus detergent for 90 min at room tem-
perature and kept in frog Ringer’s solution or same extraction buffer overnight before
incubation with TRITC-
 
a
 
BTX to label AChR and Karnovsky reaction or anti-frog
AChE antibody R80 to localize AChE. Other samples were extracted using buffers
plus or minus detergent and labeled thereafter. The colocalization of AChR and AChE
clusters exceeded 90% under the different extraction conditions, and their normal dis-
tribution persisted after overnight incubation. All values are the mean 
 
6
 
 SEM of at
least three slides per group. 
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enzyme (Fig. 3, 
 
A 
 
and 
 
B
 
). When frog muscle was incu-
bated with the globular G
 
4
 
/G
 
2
 
 AChE forms there was little
or no binding of the enzyme molecules to sites of nerve-
muscle contact represented by the clusters of AChR accu-
mulation (Fig. 3, 
 
C 
 
and 
 
D
 
). In contrast, when the frog mus-
cle sections were incubated with purified A
 
12
 
 AChE most
sites of nerve-muscle contact also had quail AChE at-
tached (Fig. 3, 
 
E 
 
and 
 
F
 
). This attachment was specific in
that inclusion of heparin in the incubation medium pre-
vented attachment of the A
 
12
 
 (Fig. 3, 
 
G 
 
and 
 
H
 
), just as it
prevented attachment of the newly synthesized AChE to
cell surface clusters on tissue-cultured myotubes (Rossi
Figure 3. Binding of collagen-tailed quail AChE molecules to frog muscle and colocalization with AChR at the neuromuscular junction.
Frozen sections of frog anterior tibialis muscle were incubated overnight with HSB containing either no exogenous quail enzyme (con-
trol, panels A–B), avian G4/G2 AChE (C–D), avian A12 AChE (E–F), or avian A12 AChE plus 1 mg/ml heparin (G–H) as described in
the text. After incubation the sections were rinsed with PBS and the quail AChE molecules localized by indirect immunofluorescence.
Sites of nerve muscle contact were visualized using TRITC-aBtx. Left panels, distribution of AChR at sites of nerve-muscle contact.
Right panels, corresponding fields showing the distribution of quail AChE molecules. Only the A12 AChE form bound to the tissue sec-
tions, where it colocalized with frog AChR, indicating that this form of the enzyme binds specifically to the neuromuscular junction. In
contrast, there is little or no binding of the globular G4/G2 forms under the same conditions.The Journal of Cell Biology, Volume 136, 1997 372
and Rotundo, 1996). These results are presented quantita-
tively in Fig. 4 showing that more than 85% of the sites of
frog nerve-muscle contact were also positive for quail
AChE, while inclusion of heparin reduced binding to
,15%.
Interestingly, re-extraction of the frog muscle sections in-
cubated with A12 AChE using high salt and detergent con-
taining buffers did not remove the quail AChE (Fig. 4). This
result is similar to observations made both on adult neuro-
muscular junctions and on tissue-cultured myotubes, indicat-
ing that once the avian A12 AChE molecules are attached,
high ionic strength buffers cannot dissociate them from the
extracellular matrix (Rossi and Rotundo, 1993, 1996).
The Collagen-tailed AChE Molecules Attach to
Specific Sites on the Synaptic Basal Lamina
The attachment of quail AChE to the frog neuromuscular
junction could occur by direct interactions with compo-
nents of the extracellular matrix or with molecules local-
ized on the postsynaptic membrane or on the nerve termi-
nal (or some combination). To distinguish between these
possibilities, empty basal lamina sheaths were prepared by
denervating the frog cutaneous pectoris muscles and de-
stroying the muscle fibers, followed by X-irradiation to
prevent fiber regeneration (Anglister et al., 1994a). After
allowing 5–6 wk for the damaged fibers and nerve termi-
nals to completely degenerate and be removed by phago-
cytosis, the empty basal lamina sheaths were dissected,
pinned out in Silgard microwells, and extracted with HSB.
The empty basal lamina sheaths were incubated in buffers
containing either the globular G4/G2 or collagen-tailed A12
AChE forms for 48 h, washed, and stained for quail AChE
using mAb 1A2 and frog AChE using enzyme histochem-
istry (Fig. 5). Only the A12 AChE bound to the empty
basal lamina sheaths where it was localized along portions
of the synaptic gutters in a pattern identical to the native
frog enzyme molecules. These results indicate that the A12
AChE molecules are binding to specific components of
the synaptic basal lamina, and moreover, that this compo-
nent(s) is highly organized along the region of the basal
lamina contacted by the nerve terminals. Furthermore, all
the components of the reaction responsible for binding the
collagen-tailed AChE to the extracellular matrix must be-
long to the extracellular matrix itself or to the purified en-
zyme, since it was possible to transplant avian A12 AChE
to the empty basal lamina sheaths.
Figure 4. Quail AChE binding to frog neuromuscular junctions.
The number of frog neuromuscular contacts, visualized using
TRITC-aBtx, that had bound avian AChE labeled with mAb
1A2 (shown in Fig. 3), were determined by counting all sites of
aBtx binding on three frozen sections of muscle per slide, with
the total from three slides averaged per group. (Cont) Control
muscle sections incubated in the absence of quail AChE; (G4/G2)
sections incubated with purified quail globular AChE forms;
(A12) sections incubated with quail collagen-tailed AChE; (Hep)
sections incubated with A12 AChE in the presence of 1 mg/ml hep-
arin; and (Re-ext) sections incubated with A12 AChE followed by
re-extraction using HSB. When incubated with the A12 form, 85
6 5% of the frog AChR sites showed quail AChE binding,
whereas only 7 6 1% of the sites had quail AChE bound when
incubated with the globular AChE forms. Addition of heparin to
the incubation mixture reduced the A12 binding to 14 6 5%.
Once the quail AChE was bound to the frog neuromuscular junc-
tions, it remained tightly attached since it could not be re-
extracted with HSB 77 6 12%.
Figure 5. Binding sites for
AChE are regularly arrayed
along the synaptic basal lam-
ina. Empty frog basal lamina
sheaths were incubated with
either the G4/G2 (A and B), or
A12 ( C  and D) quail AChE
and the neuromuscular junc-
tions localized histochemi-
cally (A and C). The quail
enzyme was labeled by indi-
rect immunofluorescence us-
ing mAb 1A2 (B and D).
Only the A12 collagen-tailed
AChE enzyme bound to the
neuromuscular junction where
it colocalized with the previ-
ously bound frog AChE.Rotundo et al. Transplantation of AChE to the Synaptic Basal Lamina 373
Discussion
The multiple oligomeric forms of AChE expressed in
nerves and muscle have been extensively studied and
much is known about their structure, synthesis, assembly,
and regulation at the cellular and molecular level. How-
ever, the mechanisms involved in localizing the newly syn-
thesized AChE molecules at cholinergic synapses are still
not well understood. In particular, the unique association
of the collagen-tailed A12 AChE form with the specialized
extracellular matrix interposed between the motor nerve
terminals and the skeletal muscle fibers, requires that a
precise targeting mechanism exist to insure the appropri-
ate distribution and density of enzyme molecules at the
neuromuscular junction as well as providing a means for
their periodic replacement.
The major events during the synthesis and assembly of
the oligomeric AChE forms in skeletal muscle are well
documented (for review see Massoulié et al., 1993). The
catalytic subunits consist of single polypeptide chains that
are cotranslationally glycosylated in the rough endoplas-
mic reticulum where they are assembled into dimers and
tetramers. After vesicular transport into the Golgi appara-
tus a subset of the oligomers are attached to the noncata-
lytic subunit, the three-stranded collagen-like tail, via di-
sulfide bonds to complete the hetero-oligomeric form
consisting of twelve catalytic subunits of z65–100 kD each
and three noncatalytic polypeptide chains of z55 kD each
for a total Mr of z1.1–1.4 million and a length of z50 nm
depending upon the species. The newly assembled A12
forms are then transported to the cell surface and exter-
nalized via fusion of the transport vesicles. In tissue cul-
tured skeletal muscle, the A12 form remains associated with
the cell surface, whereas in tissue-cultured neurons the A12
form appears to be mostly, if not entirely, secreted. Thus,
the fate of the newly synthesized A12 AChE, i.e., whether
it is released vs retained, depends upon the cell type in
which it was synthesized and the molecular composition of
its cell surface components. In tissue-cultured myotubes,
the A12 AChE molecules preferentially accumulate in cell
surface clusters in the vicinity of the myonuclei around
which they were synthesized (Rossi and Rotundo, 1992).
In vivo, the problem of targeting the A12 AChE to the
mature neuromuscular junction is more complex due to
the intricate architecture of the synaptic region and the re-
quirement that the AChE molecules lie precisely between
the neurotransmitter release sites on the nerve terminals
and the array of nicotinic acetylcholine receptors on the
postsynaptic membrane. Although there is a higher level
of AChE mRNA, as well as protein expression in inner-
vated regions of skeletal muscle fibers (Jasmin et al., 1993),
which in turn can increase localized secretion of the en-
zyme, this alone is not sufficient to insure correct organiza-
tion of the AChE molecules on the synaptic basal lamina
since many of the areas of high AChE density can be tens
of micrometers from the nearest nucleus (Fig. 1). Thus, se-
cretion followed by limited diffusion of the protein must
account, at least in part, for the distribution of AChE mol-
ecules along the synaptic basal lamina.
While limited diffusion can account for the dispersion of
A12 AChE molecules from sites of secretion on the synap-
tic sarcolemma, it cannot account for the highly organized
pattern of matrix-associated AChE interposed between
the nerve terminals and the postsynaptic membrane.
Within a species, the density of AChE molecules at the
neuromuscular junctions is remarkably constant from one
area of nerve contact to another (Anglister et al., 1994b,
and references therein). Together, these observations im-
ply that some molecular component(s) of the synaptic
basal lamina is already organized and available for the at-
tachment of the A12 AChE. That this is indeed the case is
suggested by the experiments presented in Figs. 3–5 show-
ing that only the A12 AChE form can bind to the neuro-
muscular junctions where it colocalizes with AChRs.
Although the molecule(s) to which the A12 AChE bind
have not yet been identified, there is strong indirect evi-
dence to suggest that it may be a heparan sulfate-like pro-
teoglycan localized in the extracellular matrix. Early stud-
ies on the structure and membrane association of AChE
from Torpedo electric organs showed that the collagen-
tailed, but not the globular forms, could associate with
fragments of the extracellular matrix isolated by sucrose
gradient centrifugation (Lwebuga-Mukasa et al., 1976).
The collagenic tail of AChE contains a heparin-binding
domain (Deprez and Inestrosa, 1995) and can specifically
associate with heparan sulfate glycosaminoglycans (Bon
et al., 1978; Vigny et al., 1983; Brandan et al., 1985). A spe-
cific heparan sulfate proteoglycan is highly concentrated
at the vertebrate neuromuscular junction (Anderson and
Fambrough, 1983; Bayne et al., 1984; Sanes et al., 1986;
Swenarchuk et al., 1990), where its distribution correlates
very closely with AChE. Whether AChE attaches only to
this sulfated proteoglycan or to other molecules with simi-
lar sulfated carbohydrates remains to be determined.
Based upon the above observations and our present
studies, a plausible mechanism for localizing AChE on the
synaptic basal lamina would be that the newly synthesized
A12 AChE molecules, preferentially expressed in inner-
vated regions of the fibers, would be secreted into the
space between the sarcolemma and the overlying synaptic
basal lamina. The space would afford limited diffusion of
these large molecules until they could interact electrostati-
cally with the appropriate heparan sulfate proteoglycans.
This interaction would be transient (Rossi and Rotundo,
1996) until additional events resulted in a more permanent
form of attachment, such as formation of covalent bonds
with neighboring molecules or additional intrachain disul-
fide bonds within the collagen-like tail subunits (Krejci et al.,
1991). The A12 AChE would then remain attached to the
synaptic basal lamina until it was detached via some as yet
unknown, but possibly enzymatic, mechanism. To date,
the only available quantitative data on turnover of AChE
at the neuromuscular junction indicates that it has a rela-
tively long half life of z20 d and is removed by a process
that exhibits first order decay kinetics (Kasprzak and Sal-
peter, 1985). A specific attachment site on the synaptic
basal lamina would therefore be the molecular equivalent
of a space in a “parking lot,” whereby the newly synthe-
sized collagen-tailed AChE molecules could be inserted
and removed in the region between the nerve terminals
and the acetylcholine receptors, as necessary. Further-
more, these studies also emphasize the fact that, despite
differences in the underlying cellular and molecular mech-
anisms regulating AChE biogenesis between amphibiansThe Journal of Cell Biology, Volume 136, 1997 374
and aves, similar mechanisms determine the ultimate num-
bers and patterns of distribution of AChE molecules at the
neuromuscular synapse.
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